A homogeneous treatment for non-DIPG diffuse midline glioma.

Elisabetta SchiavelloVeronica BiassoniGiovanna GattusoMarta PoddaStefano ChiaravalliFrancesco BarrettaManila AntonelliLoris De CeccoEmilia PecoriLorenza GandolaMaura Massimino

Published in: Tumori (2022)

This is a small series of homogeneously-treated DMG patients. The results obtained are comparable with those of DIPG patients. Given the phenotypically- and molecularly-defined setting of DMG and severe outcome in this orphan population, they should be treated and included in registries and protocols of DIPG.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
early onset
patient reported outcomes
high grade